IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com ASX Announcement Amendment of Convertible Notes Sydney, Australia, 21 August, 2026: Imugene Limited (ASX:IMU) (Imugene or Company), a clinical stage immuno-oncology company, is pleased to announce that it has...